HONG KONG, August 19, 2026 – (ACN Newswire) – Everest Medicines (01952.HK) announced its interim results for the six months ended June 30, 2026. Everest […]
Tag: Medicines
Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
HONG KONG, Aug 14, 2025 – (ACN Newswire) – Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially […]
Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan
HONG KONG, Aug 8, 2025 – (ACN Newswire) – Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the […]